Get started
Market_Referee

Upgrade a Arbutus Biopharma

Long
Arbutus Biopharma Corporation (NASDAQ:ABUS)  
Market_Referee  
NASDAQ:ABUS   Arbutus Biopharma Corporation
Trend Analysis Beyond Technical Analysis biopharma upgrade
0
0
trendanalysis beyondta biopharma upgrade
Le han subido el rating a Outperform.
Las cifras de consenso para los ingresos y las ganancias por acción (EPS) aumentaron, con perspectivas optimistas
Views and opinions for informational purposes only. Remember, past performance is no guarantee of future results.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.